Prescription Drug News and Research

RSS

The Waismann Method of Accelerated Benzodiazepine Neuro-Regulation proves a suitable alternative to traditional benzodiazepine detoxification

The Waismann Method of Accelerated Benzodiazepine Neuro-Regulation (ABNR) involves a safe, medically-assisted withdrawal from Benzodiazepines in a hospital setting. This advanced approach to Benzodiazepine withdrawal offers patients another alternative to traditional benzodiazepine detoxification, which even when done gradually, can be extremely dangerous and even life threatening.

29 Aug 2009

Ipsen Group announces first-half 2009 financial results

The Board of Directors of Ipsen (Paris:IPN), chaired by Jean-Luc Bélingard, met on 27 August 2009 to review the Group’s results for the first half 2009, published today. The full 2009 half year financial report is available on the Group’s web site, www.ipsen.com, under the Regulated Information heading in the Investor Relations pages.

28 Aug 2009

Senior citizens are paying escalating cost for their health care says HHS Secretary Kathleen Sebelius

HHS Secretary Kathleen Sebelius today issued a new report, America’s Seniors and Health Insurance Reform: Protecting Coverage and Strengthening Medicare. The report highlights the problems with the status quo that leave seniors paying escalating costs for their health care while outlining how health insurance reform will strengthen Medicare and protect coverage for seniors.

28 Aug 2009

Prescription Solutions launches consumer website that features updated content and drug pricing tool

Prescription Solutions, a leading pharmacy benefits management organization and a UnitedHealth Group (NYSE: UNH) company, today announced the launch of its refreshed consumer website, www.PrescriptionSolutions.com, featuring enhanced functionality, updated content, and simplified navigation. The site makes prescription drug information more accessible and provides education customers need to make informed health care choices.

27 Aug 2009

Walgreens collaborates with Caterpillar to provide transparent prescription drug pricing for employers

Walgreens today announced an agreement with Caterpillar Inc. (NYSE: CAT) that establishes a direct relationship for the purchase of prescription drugs using a transparent pricing model.

27 Aug 2009

Sen. Edward M. Kennedy -- health care champion -- dies

Sen. Edward M. Kennedy had a hand in nearly every piece of health care legislation that moved through Congress during his eight-term Senate tenure. He died Tuesday night of brain cancer at age 77.

27 Aug 2009

FDA to review Acorda Therapeutics’ NDA for Fampridine-SR

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the U.S. Food and Drug Administration (FDA) has confirmed that its Peripheral and Central Nervous System Drugs Advisory Committee will review the Company’s New Drug Application (NDA) for Fampridine-SR on October 14, 2009.

26 Aug 2009

FDA accepts Labopharm's response for its novel trazodone formulation

Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced the U.S. Food and Drug Administration (FDA) has accepted Labopharm's response regarding its novel formulation of the antidepressant trazodone as complete and designated it as a Class 2 resubmission. The FDA has assigned Labopharm a new Prescription Drug User Fee Act (PDUFA) action date of February 11, 2010.

26 Aug 2009

Gloucester Pharmaceuticals raises funds for the development of romidepsin

Gloucester Pharmaceuticals today announced that it has raised $29 million in a Series D financing. The proceeds will be used to support the ongoing development of romidepsin, a novel histone deacetylase (HDAC) inhibitor for the treatment of T-cell lymphomas and other hematologic malignancies.

26 Aug 2009

Customized health plan introduced by American Community

As Nebraska employers seek out additional ways to reduce rising healthcare costs, American Community Mutual Insurance Company announced today the addition of Latitude(TM), a small group product that allows employers to customize a health plan with the benefits that employees want at a price that business owners can afford.

26 Aug 2009

Medicare's Part D program subsidizes cost of prescription drugs for Medicare beneficiaries

Medicare's Part D program, designed to subsidize the cost of prescription drugs for Medicare beneficiaries, has been the subject of much debate. Proponents have touted the plan's ability to expand access to prescription drugs to seniors; critics have long questioned its design and user-friendly appeal.

26 Aug 2009

FDA accepts for filing Salix Pharmaceuticals' NDA for rifaximin tablets

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced the Food and Drug Administration (FDA) has accepted for filing and designated for Priority Review the Company’s New Drug Application (NDA) for rifaximin tablets 550 mg for the maintenance of remission of hepatic encephalopathy (HE). Additionally, the FDA has informed the Company of its plan to schedule an Advisory Committee meeting in late February 2010 to discuss the application.

25 Aug 2009

New RAND study finds that Prescription Benefit Program for Medicare recipients surpasses expectations

The program created to provide Medicare recipients with prescription drug benefits exceeded expectations during its first two years, extending pharmacy coverage to most seniors while reducing their overall spending on drugs, according to a new RAND Corporation study.

25 Aug 2009

P&G's global pharmaceuticals business sold to Warner Chilcott for $3.1 billion

The Procter & Gamble Company and Warner Chilcott plc today announced an agreement for the sale of P&G's global pharmaceuticals business to Warner Chilcott for an up-front cash payment of $3.1 billion.

24 Aug 2009

Cell Therapeutics' NDA for Pixantrone accepted by the FDA

Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that the U.S. Food and Drug Administration (FDA) has accepted and has filed for review the Company's New Drug Application (NDA) for pixantrone as treatment for relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL). A Prescription Drug User Fee Act (PDUFA) date will be established by the FDA regarding the review of the pixantrone NDA by September 4th 2009.

24 Aug 2009

Physicians lack knowledge of off-label drug use and FDA approval status

In a recent national survey, a substantial minority of physicians erroneously believed that certain off-label uses of prescription drugs were approved by the Food and Drug Administration. This mistaken belief could encourage them to prescribe these drugs, despite the lack of scientific evidence supporting such use.

21 Aug 2009

Shareholders of Medarex get more time to accept cash tender offer from Bristol-Myers Squibb Company

Bristol-Myers Squibb Company (NYSE: BMY) announced today that it has extended its previously announced cash tender offer, through its wholly-owned subsidiary, Puma Acquisition Corporation, to purchase all outstanding shares of common stock of Medarex (NASDAQ: MEDX) (“Medarex”) until 12:00 midnight (New York City time) on August 26, 2009, unless further extended.

21 Aug 2009

Newspapers examine debate over affordable drugs in developing countries

The Los Angeles Times examines how "activists in Washington, and Thailand and other developing countries are accusing the Obama administration of endangering access to affordable drugs to fight AIDS and other epidemic diseases."

21 Aug 2009

Consumer groups urge transparency in health care reform for pharmacy benefit managers

Three top consumer groups are urging Congress to include in health care reform legislation transparency requirements for pharmacy benefit managers (PBMs) participating in any new federally sponsored health plans in a public health care exchange. The Consumer Federation of America (CFA), U.S. Public Interest Research Group (PIRG), and the National Legislative Association on Prescription Drug Prices (NLARx) have sent a joint letter to House Speaker Nancy Pelosi (D-CA) supporting the provision, authored by Rep. Anthony Weiner (D-NY) and included in the House Energy and Commerce Committee’s America’s Affordable Health Choices Act of 2009 (H.R. 3200).

20 Aug 2009

State round-up: New Jersey hospitals, Utah's Medicaid troubles, and more

Wednesday's state news includes a hospital demonstration in New Jersey, Medicaid fraud in Utah, an abortion ruling in Oklahoma, and a White House decision to maintain Wisconsin's unique drug program for seniors.

20 Aug 2009

Prescription Drug News and Research

The Waismann Method of Accelerated Benzodiazepine Neuro-Regulation proves a suitable alternative to traditional benzodiazepine detoxification

Ipsen Group announces first-half 2009 financial results

Senior citizens are paying escalating cost for their health care says HHS Secretary Kathleen Sebelius

Prescription Solutions launches consumer website that features updated content and drug pricing tool

Walgreens collaborates with Caterpillar to provide transparent prescription drug pricing for employers

Sen. Edward M. Kennedy -- health care champion -- dies

FDA to review Acorda Therapeutics’ NDA for Fampridine-SR

FDA accepts Labopharm's response for its novel trazodone formulation

Gloucester Pharmaceuticals raises funds for the development of romidepsin

Customized health plan introduced by American Community

Medicare's Part D program subsidizes cost of prescription drugs for Medicare beneficiaries

FDA accepts for filing Salix Pharmaceuticals' NDA for rifaximin tablets

New RAND study finds that Prescription Benefit Program for Medicare recipients surpasses expectations

P&G's global pharmaceuticals business sold to Warner Chilcott for $3.1 billion

Cell Therapeutics' NDA for Pixantrone accepted by the FDA

Physicians lack knowledge of off-label drug use and FDA approval status

Shareholders of Medarex get more time to accept cash tender offer from Bristol-Myers Squibb Company

Newspapers examine debate over affordable drugs in developing countries

Consumer groups urge transparency in health care reform for pharmacy benefit managers

State round-up: New Jersey hospitals, Utah's Medicaid troubles, and more

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News